Literature DB >> 11431364

An intact overexpressed E-cadherin/alpha,beta-catenin axis characterizes the lymphovascular emboli of inflammatory breast carcinoma.

J S Tomlinson1, M L Alpaugh, S H Barsky.   

Abstract

The step of intravasation (lymphovascular invasion), a rate-limiting step in metastasis, is greatly exaggerated in inflammatory breast carcinoma (IBC). Because nearly all human breast carcinoma cell lines grow as solitary nodules in nude/severe combined immunodeficient mice without manifesting lymphovascular invasion, this step has been difficult to study. We captured the essence of the IBC phenotype by establishing a unique human transplantable IBC xenograft, MARY-X, which manifests florid lymphovascular emboli in severe combined immunodeficient/nude mice. Comparing MARY-X with common non-IBC cell lines/xenografts, we discovered an overexpressed and overfunctioning E-cadherin/alpha,beta-catenin axis. In MARY-X, the E-cadherin and catenins were part of a structurally and functionally intact adhesion axis involving the actin cytoskeleton. In vitro, MARY-X grew as round compact spheroids with a cell density 5-10-fold higher than that of other lines. The spheroids of MARY-X completely disadhered when placed in media containing absent Ca(2+) or anti-E-cadherin antibodies or when retrovirally transfected with a dominant-negative E-cadherin mutant (H-2K(d)-E-cad). Anti-E-cadherin antibodies injected i.v. immunolocalized to the pulmonary lymphovascular emboli of MARY-X and caused their dissolution. H-2K(d)-E-cad-transfected MARY-X spheroids were only weakly tumorigenic and did not form lymphovascular emboli. A total of 90% of human IBCs showed increased membrane E-cadherin/alpha,beta-catenin immunoreactivity. These findings indicate that it is the gain and not the loss of the E-cadherin axis that contributes to the IBC phenotype.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11431364

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  54 in total

Review 1.  Inflammatory breast cancer: what we know and what we need to learn.

Authors:  Hideko Yamauchi; Wendy A Woodward; Vicente Valero; Ricardo H Alvarez; Anthony Lucci; Thomas A Buchholz; Takayuki Iwamoto; Savitri Krishnamurthy; Wei Yang; James M Reuben; Gabriel N Hortobágyi; Naoto T Ueno
Journal:  Oncologist       Date:  2012-05-14

2.  Ganoderma lucidum (Reishi) inhibits cancer cell growth and expression of key molecules in inflammatory breast cancer.

Authors:  Michelle M Martínez-Montemayor; Raysa Rosario Acevedo; Elisa Otero-Franqui; Luis A Cubano; Suranganie F Dharmawardhane
Journal:  Nutr Cancer       Date:  2011-09-02       Impact factor: 2.900

3.  Gain in cellular organization of inflammatory breast cancer: A 3D in vitro model that mimics the in vivo metastasis.

Authors:  Jorge Morales; Mary L Alpaugh
Journal:  BMC Cancer       Date:  2009-12-23       Impact factor: 4.430

Review 4.  E-cadherin's dark side: possible role in tumor progression.

Authors:  Fausto J Rodriguez; Laura J Lewis-Tuffin; Panos Z Anastasiadis
Journal:  Biochim Biophys Acta       Date:  2012-03-13

5.  Differential expression of E-cadherin, β-catenin, and Lewis x between invasive hydatidiform moles and post-molar choriocarcinomas.

Authors:  Jean-Jacques Candelier; Lucien Frappart; Ange Lucien Diatta; Tarik Yadaden; Mamadou-Lamine Cissé; Jean-Marie Afoutou; Jean-Yves Picard; Benoît Mennesson; Rima Slim; Karim Si-Tayeb; Philippe Coullin
Journal:  Virchows Arch       Date:  2013-05-17       Impact factor: 4.064

6.  Dominant-negative E-cadherin inhibits the invasiveness of inflammatory breast cancer cells in vitro.

Authors:  Hui-Ming Dong; Gang Liu; Yi-Feng Hou; Jiong Wu; Jin-Song Lu; Jian-Min Luo; Zhen-Zhou Shen; Zhi-Ming Shao
Journal:  J Cancer Res Clin Oncol       Date:  2006-08-24       Impact factor: 4.553

7.  Relationship of sialyl-Lewis(x/a) underexpression and E-cadherin overexpression in the lymphovascular embolus of inflammatory breast carcinoma.

Authors:  Mary L Alpaugh; James S Tomlinson; Yin Ye; Sanford H Barsky
Journal:  Am J Pathol       Date:  2002-08       Impact factor: 4.307

8.  Functional gene expression analysis uncovers phenotypic switch in aggressive uveal melanomas.

Authors:  Michael D Onken; Justis P Ehlers; Lori A Worley; Jun Makita; Yoshifumi Yokota; J William Harbour
Journal:  Cancer Res       Date:  2006-05-01       Impact factor: 12.701

9.  Molecular plasticity of E-cadherin and sialyl lewis x expression, in two comparative models of mammary tumorigenesis.

Authors:  Salomé S Pinho; Celso A Reis; Fátima Gärtner; Mary L Alpaugh
Journal:  PLoS One       Date:  2009-08-13       Impact factor: 3.240

10.  Prognostic impact of human epidermal growth factor-like receptor 2 and hormone receptor status in inflammatory breast cancer (IBC): analysis of 2,014 IBC patient cases from the California Cancer Registry.

Authors:  Jason A Zell; Walter Y Tsang; Thomas H Taylor; Rita S Mehta; Hoda Anton-Culver
Journal:  Breast Cancer Res       Date:  2009-02-19       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.